← Back to headlines
AstraZeneca Advances Weight-Loss Pill Development
AstraZeneca is progressing with its weight-loss pill, aiming to compete with market leaders Novo Nordisk and Eli Lilly in the obesity treatment sector.
8 Jun, 20:15 — 8 Jun, 20:15
Sources
Showing 1 of 1 sources



